UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004563 |
|---|---|
| Receipt number | R000005452 |
| Scientific Title | A phase II study of Erlotinib for patients previously treated non-small cell lung cancer with epidermal growth factor receptor mutation |
| Date of disclosure of the study information | 2010/11/15 |
| Last modified on | 2018/11/24 21:35:17 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/11/15 22:24:42 | ||
| 2 | Update | 2012/12/10 22:13:31 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2018/11/24 21:34:38 | Address Address TEL Last name of contact person Last name of contact person Address Address Name of primary person or sponsor Institute Organization |
|
| 4 | Update | 2018/11/24 21:35:17 | Recruitment status |
